Insights

Minaris Regenerative Medicine’s leaders and experts are proud to share their knowledge and insight with the cell and gene therapy industry. Please review our current and past blog posts on topics of interest to this emerging industry.

    *This page may include mention of our past company names as it reflects content distributed in the past. The former companies Hitachi Chemical Advanced Therapeutics Solutions (HCATS, formerly PCT or PCT Cell Therapy Services), apceth Biopharma GmBH are all now operations under the name Minaris Regenerative Medicine. Hitachi Chemical Co., Ltd. has been renamed Showa Denko Materials Co., Ltd.
    November 2, 2017

    Robert Preti, PhD, Opens the 2017 Cell & Gene Meeting on the Mesa

    At this year's Cell & Gene Meeting on the Mesa, Robert Preti, PhD, Chairman of the Alliance for Regenerative Medicine and President and CEO of Hitachi Chemical ...

    Read More
    May 15, 2017

    Executive Interview - PCT: Manufacturing the Future of Cell Therapies

    In an interview published in the May 2017 issue of Drug Development & Delivery, PCT President Robert Preti, PhD, discusses PCT’s founding, differentiators, growth, ...

    Read More
    February 16, 2017

    Challenges and Optimization of Apheresis Collection

    On Thursday, February 23 from 2:00 – 3:30 PM EST, Sanjin Zvonic, PhD, PCT’s Senior Director, Business Leader, Clinical Cell Therapy Manufacturing, will be speaking as ...

    Read More
    April 27, 2016

    Patient-Specific Cell Therapies: Not your Grandfather’s Therapies

    The following is an excerpt from an article published in the April issue of BioProcess international, entitled “Factories of the Future: Can Patient-Specific Cell ...

    Read More
    February 12, 2016

    The Passion for and Potential of T Cells: Expert Insights

    1. Why are T cells promising/exciting in cell therapy right now? What potential do you see? “T cells play a central role in the immune response, as they have the ...

    Read More
    All Posts

    Subscribe to Our Email Distribution List
    © 2025 Minaris Regenerative Medicine   |  Privacy Policy   |  Imprint